Analyst Ratings For NYSE:GMED – Globus Medical (NYSE:GMED)
Today, Leerink Swann raised its price target on NYSE:GMED – Globus Medical (NYSE:GMED) to per share.
Some recent analyst ratings include
- 4/16/2018-BTIG Research Reiterated Rating of Buy ➝ Neutral.
- 3/12/2018-Canaccord Genuity Reiterated Rating of Buy.
- 1/10/2018-Barclays Reiterated Rating of Sell.
Recent Insider Trading Activity For NYSE:GMED – Globus Medical (NYSE:GMED)
NYSE:GMED – Globus Medical (NYSE:GMED) has insider ownership of 28.44% and institutional ownership of 62.82%.
- On 4/30/2018 David C Paul, Insider, sold 827,004 with an average share price of $51.81 per share and the total transaction amounting to $42,847,077.24.
- On 4/26/2018 David C Paul, Chairman, sold 725,000 with an average share price of $51.81 per share and the total transaction amounting to $37,562,250.00.
- On 4/19/2018 David M Demski, CEO, sold 149,109 with an average share price of $51.00 per share and the total transaction amounting to $7,604,559.00.
- On 4/13/2018 David M Demski, CEO, sold 50,891 with an average share price of $51.00 per share and the total transaction amounting to $2,595,441.00.
- On 4/10/2018 Daniel T Scavilla, VP, sold 100,000 with an average share price of $50.00 per share and the total transaction amounting to $5,000,000.00.
- On 3/28/2018 Eric Schwartz, VP, sold 24,000 with an average share price of $50.00 per share and the total transaction amounting to $1,200,000.00.
- On 12/15/2017 Steven Payne, CAO, sold 3,076 with an average share price of $39.30 per share and the total transaction amounting to $120,886.80.
Recent Trading Activity for NYSE:GMED – Globus Medical (NYSE:GMED)
Shares of NYSE:GMED – Globus Medical closed the previous trading session at 55.76 up +1.14 2.09% with 55.0 shares trading hands.